NCT02693639

Brief Summary

The purpose of this study is to determine prediction value of PANX1 expression in infection post liver transplantation.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2016

Longer than P75 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2016

Completed
16 days until next milestone

First Submitted

Initial submission to the registry

February 17, 2016

Completed
12 days until next milestone

First Posted

Study publicly available on registry

February 29, 2016

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2020

Completed
Last Updated

February 29, 2016

Status Verified

February 1, 2016

Enrollment Period

4 years

First QC Date

February 17, 2016

Last Update Submit

February 23, 2016

Conditions

Infection

Keywords

PANX1InfectionLiver transplantation

Outcome Measures

Primary Outcomes (1)

  • Post-transplant infections

    Frequency of clinically or microbiologically documented infection after transplantation.

    90 days

Study Arms (1)

liver transplantation grafts

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients underwent liver transplantation.

You may qualify if:

  • patients underwent liver transplantation.

You may not qualify if:

  • re-transplantation
  • multiorgan transplantation
  • living donors or split-liver donors liver transplantation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Infections

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Director of department of liver transplantation

Study Record Dates

First Submitted

February 17, 2016

First Posted

February 29, 2016

Study Start

February 1, 2016

Primary Completion

February 1, 2020

Study Completion

February 1, 2020

Last Updated

February 29, 2016

Record last verified: 2016-02